Finance

Lists
ZYDUSLIFE:NSE
Zydus Lifesciences Ltd
1 123,00 ₹
-1,51%
(-17,20) 1D
16 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSLIFE...
Open
1 140,10 ₹
High
1 146,50 ₹
Low
1 123,00 ₹
Mkt. cap
1,12 трлн
Avg. vol.
1,42 млн
Volume
1,60 млн
Dividend
0,09%
Quarterly dividend
0,25 ₹
Ex-dividend date
2026 ж. 24 шіл.
P/E ratio
25,03
52-wk high
1 232,10 ₹
52-wk low
835,50 ₹
EPS
44,87 ₹
No. of employees
30 мың
Open
1 140,10 ₹
High
1 146,50 ₹
Low
1 123,00 ₹
Mkt. cap
1,12 трлн
Avg. vol.
1,42 млн
Volume
1,60 млн
Dividend
0,09%
Quarterly dividend
0,25 ₹
Ex-dividend date
2026 ж. 24 шіл.
P/E ratio
25,03
52-wk high
1 232,10 ₹
52-wk low
835,50 ₹
EPS
44,87 ₹
No. of employees
30 мың
News stories
From web sources and news partners
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd
CEO-
Employees30 мың
Founded1952
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 11 там.
Fiscal period
Q1 2027
9,48 ₹ / 11,15 ₹
-14,98%miss
Revenue / Est. (INR)
80,17 млрд / 76,87 млрд
+4,30%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
61,23 млрд
68,64 млрд
75,87 млрд
80,17 млрд
Cost of goods sold
16,90 млрд
18,36 млрд
22,07 млрд
22,40 млрд
Cost of revenue
16,90 млрд
18,36 млрд
22,07 млрд
22,40 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,34 млрд
11,40 млрд
32,92 млрд
13,68 млрд
Operating expense
31,33 млрд
37,36 млрд
39,40 млрд
44,59 млрд
Total operating expenses
48,23 млрд
55,72 млрд
61,48 млрд
66,99 млрд
Operating income
13,00 млрд
12,92 млрд
14,39 млрд
13,18 млрд
Other non operating income
1,09 млрд
1,11 млрд
-3,70 млрд
1,06 млрд
EBT including unusual items
16,93 млрд
14,11 млрд
16,59 млрд
13,44 млрд
EBT excluding unusual items
17,27 млрд
14,96 млрд
20,88 млрд
13,63 млрд
Income tax expense
4,54 млрд
3,88 млрд
3,18 млрд
3,54 млрд
Effective tax rate
26,82%
27,52%
19,19%
26,35%
Other operating expenses
17,97 млрд
22,36 млрд
1,28 млрд
25,36 млрд
Net income
12,59 млрд
10,42 млрд
12,72 млрд
9,40 млрд
Net profit margin
20,55%
15,18%
16,77%
11,72%
Earnings per share
12,76
10,96
15,84
9,48
Interest and investment income
-
-
4,24 млрд
-
Interest expense
-1,01 млрд
-1,30 млрд
-491,00 млн
-1,56 млрд
Net interest expenses
-1,01 млрд
-1,30 млрд
3,75 млрд
-1,56 млрд
Depreciation and amortization charges
3,02 млрд
3,60 млрд
5,08 млрд
5,55 млрд
EBITDA
15,70 млрд
15,10 млрд
17,74 млрд
16,53 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары